S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company

Chinook Therapeutics (KDNY) Insider Trading & Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$40.39
▼
$40.39
50-Day Range
$38.66
▼
$40.39
52-Week Range
$18.34
▼
$40.51
Volume
N/A
Average Volume
1.19 million shs
Market Capitalization
$2.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.14
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media

Chinook Therapeutics (NASDAQ:KDNY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.79%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$17.71 M
Get KDNY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Chinook Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KDNY Insider Buying and Selling by Quarter


Chinook Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/1/2023Andrew James KingInsiderSell1,168$39.03$45,587.04  
5/30/2023William Mariner GreenmanDirectorSell1,155$23.30$26,911.50  
4/24/2023Eric DobmeierCEOSell23,800$21.58$513,604.00  
4/17/2023Davis JerelDirectorSell295,808$20.75$6,138,016.00  
4/4/2023Mahesh KrishnanDirectorSell924$23.01$21,261.24  
4/3/2023Andrew James KingInsiderSell5,000$23.34$116,700.00  
3/1/2023Davis JerelDirectorSell400,000$22.75$9,100,000.00  
2/10/2023Andrew James KingInsiderSell2,392$23.75$56,810.00  
2/10/2023Eric BjerkholtCFOSell857$23.75$20,353.75  
2/10/2023Eric DobmeierCEOSell8,097$23.75$192,303.75  
2/10/2023Tom FrohlichCOOSell3,700$23.75$87,875.00  
1/31/2023Andrew James KingInsiderSell3,244$24.68$80,061.92  
1/31/2023Eric BjerkholtCFOSell2,891$24.68$71,349.88  
1/31/2023Tom FrohlichCOOSell4,566$24.68$112,688.88  
1/30/2023Eric DobmeierCEOSell25,000$24.54$613,500.00  
1/3/2023Andrew James KingInsiderSell10,000$25.82$258,200.00  
12/13/2022Tom FrohlichCOOSell10,000$25.00$250,000.00  
(Data available from 1/1/2013 forward)












KDNY Insider Trading Activity - Frequently Asked Questions

Who is on Chinook Therapeutics's Insider Roster?

The list of insiders at Chinook Therapeutics includes Alan Glicklich, Andrew James King, Davis Jerel, Eric Bjerkholt, Eric Dobmeier, Mahesh Krishnan, Srinivas Akkaraju, Tom Frohlich, Versant Venture Capital Vii, L, and William Mariner Greenman. Learn more on insiders at KDNY.

What percentage of Chinook Therapeutics stock is owned by insiders?

16.79% of Chinook Therapeutics stock is owned by insiders. Learn more on KDNY's insider holdings.

Which Chinook Therapeutics insiders have been buying company stock?

The following insider purchased KDNY shares in the last 24 months: Eric Dobmeier ($65,150.00).

How much insider buying is happening at Chinook Therapeutics?

Insiders have purchased a total of 5,000 KDNY shares in the last 24 months for a total of $65,150.00 bought.

Which Chinook Therapeutics insiders have been selling company stock?

The following insiders have sold KDNY shares in the last 24 months: Andrew James King ($960,421.29), Davis Jerel ($31,238,016.00), Eric Bjerkholt ($231,719.23), Eric Dobmeier ($1,988,707.75), Mahesh Krishnan ($21,261.24), Tom Frohlich ($864,666.18), Versant Venture Capital Vii, L ($9,600,000.00), and William Mariner Greenman ($26,911.50).

How much insider selling is happening at Chinook Therapeutics?

Insiders have sold a total of 2,479,919 Chinook Therapeutics shares in the last 24 months for a total of $44,931,703.19 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:KDNY) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -